1
|
Wang Y. Multidisciplinary Advances Address the Challenges in Developing Drugs against Transient Receptor Potential Channels to Treat Metabolic Disorders. ChemMedChem 2023; 18:e202200562. [PMID: 36530131 DOI: 10.1002/cmdc.202200562] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 12/01/2022] [Accepted: 12/16/2022] [Indexed: 12/23/2022]
Abstract
Transient receptor potential (TRP) channels are cation channels that regulate key physiological and pathological processes in response to a broad range of stimuli. Moreover, they systemically regulate the release of hormones, metabolic homeostasis, and complications of diabetes, which positions them as promising therapeutic targets to combat metabolic disorders. Nevertheless, there are significant challenges in the design of TRP ligands with high potency and durability. Herein we summarize the four challenges as hydrophobicity, selectivity, mono-target therapy, and interspecies discrepancy. We present 1134 TRP ligands with diversified modes of TRP-ligand interaction and provide a detailed discussion of the latest strategies, especially cryogenic electron microscopy (cryo-EM) and computational methods. We propose solutions to address the challenges with a critical analysis of advances in membrane partitioning, polypharmacology, biased agonism, and biochemical screening of transcriptional modulators. They are fueled by the breakthrough from cryo-EM, chemoinformatics and bioinformatics. The discussion is aimed to shed new light on designing next-generation drugs to treat obesity, diabetes and its complications, with optimal hydrophobicity, higher mode selectivity, multi-targeting and consistent activities between human and rodents.
Collapse
Affiliation(s)
- Yibing Wang
- School of Kinesiology, Shanghai University of Sport, Shanghai, 200438, P. R. China.,Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai, 200438, P. R. China
| |
Collapse
|
2
|
Araújo MC, Soczek SHS, Pontes JP, Marques LAC, Santos GS, Simão G, Bueno LR, Maria-Ferreira D, Muscará MN, Fernandes ES. An Overview of the TRP-Oxidative Stress Axis in Metabolic Syndrome: Insights for Novel Therapeutic Approaches. Cells 2022; 11:cells11081292. [PMID: 35455971 PMCID: PMC9030853 DOI: 10.3390/cells11081292] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 03/19/2022] [Accepted: 04/05/2022] [Indexed: 02/06/2023] Open
Abstract
Metabolic syndrome (MS) is a complex pathology characterized by visceral adiposity, insulin resistance, arterial hypertension, and dyslipidaemia. It has become a global epidemic associated with increased consumption of high-calorie, low-fibre food and sedentary habits. Some of its underlying mechanisms have been identified, with hypoadiponectinemia, inflammation and oxidative stress as important factors for MS establishment and progression. Alterations in adipokine levels may favour glucotoxicity and lipotoxicity which, in turn, contribute to inflammation and cellular stress responses within the adipose, pancreatic and liver tissues, in addition to hepatic steatosis. The multiple mechanisms of MS make its clinical management difficult, involving both non-pharmacological and pharmacological interventions. Transient receptor potential (TRP) channels are non-selective calcium channels involved in a plethora of physiological events, including energy balance, inflammation and oxidative stress. Evidence from animal models of disease has contributed to identify their specific contributions to MS and may help to tailor clinical trials for the disease. In this context, the oxidative stress sensors TRPV1, TRPA1 and TRPC5, play major roles in regulating inflammatory responses, thermogenesis and energy expenditure. Here, the interplay between these TRP channels and oxidative stress in MS is discussed in the light of novel therapies to treat this syndrome.
Collapse
Affiliation(s)
- Mizael C. Araújo
- Programa de Pós-Graduação, Universidade CEUMA, São Luís 65075-120, MA, Brazil; (M.C.A.); (G.S.S.)
| | - Suzany H. S. Soczek
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80250-060, PR, Brazil; (S.H.S.S.); (G.S.); (L.R.B.); (D.M.-F.)
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil
| | - Jaqueline P. Pontes
- Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Maranhão, São Luís 565085-080, MA, Brazil;
| | - Leonardo A. C. Marques
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, SP, Brazil; (L.A.C.M.); (M.N.M.)
| | - Gabriela S. Santos
- Programa de Pós-Graduação, Universidade CEUMA, São Luís 65075-120, MA, Brazil; (M.C.A.); (G.S.S.)
| | - Gisele Simão
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80250-060, PR, Brazil; (S.H.S.S.); (G.S.); (L.R.B.); (D.M.-F.)
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil
| | - Laryssa R. Bueno
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80250-060, PR, Brazil; (S.H.S.S.); (G.S.); (L.R.B.); (D.M.-F.)
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil
| | - Daniele Maria-Ferreira
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80250-060, PR, Brazil; (S.H.S.S.); (G.S.); (L.R.B.); (D.M.-F.)
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil
| | - Marcelo N. Muscará
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, SP, Brazil; (L.A.C.M.); (M.N.M.)
| | - Elizabeth S. Fernandes
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba 80250-060, PR, Brazil; (S.H.S.S.); (G.S.); (L.R.B.); (D.M.-F.)
- Programa de Pós-Graduação em Biotecnologia Aplicada à Saúde da Criança e do Adolescente, Faculdades Pequeno Príncipe, Curitiba 80230-020, PR, Brazil
- Correspondence:
| |
Collapse
|
3
|
Kazancioglu MZ, Quirion K, Wipf P, Skoda EM. Enantioselective synthesis and selective functionalization of 4-aminotetrahydroquinolines as novel GLP-1 secretagogues. Chirality 2022; 34:521-536. [PMID: 34964164 PMCID: PMC8837726 DOI: 10.1002/chir.23403] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Revised: 12/01/2021] [Accepted: 12/07/2021] [Indexed: 01/28/2023]
Abstract
Polysubstituted tetrahydroquinolines were obtained in moderate to high yields (28% to 92%) and enantiomeric ratios (er 89:11 to 99:1) by a three-component Povarov reaction using a chiral phosphoric acid catalyst. Significantly, post-Povarov functional group interconversions allowed a rapid access to a library of 36 enantioenriched 4-aminotetrahydroquinoline derivatives featuring five points of diversity. Selected analogs were assayed for their ability to function as glucagon-like peptide-1 (GLP-1) secretagogues.
Collapse
Affiliation(s)
- Mustafa Z. Kazancioglu
- Department of Chemistry, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, PA 15260, USA
| | - Kevin Quirion
- Department of Chemistry, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, PA 15260, USA
| | - Peter Wipf
- Department of Chemistry, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, PA 15260, USA.,Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA
| | - Erin M. Skoda
- Department of Chemistry, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, PA 15260, USA
| |
Collapse
|
4
|
Zhu Y, Zhao J, Luo L, Gao Y, Bao H, Li P, Zhang H. Research progress of indole compounds with potential antidiabetic activity. Eur J Med Chem 2021; 223:113665. [PMID: 34192642 DOI: 10.1016/j.ejmech.2021.113665] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 06/19/2021] [Accepted: 06/20/2021] [Indexed: 01/07/2023]
Abstract
New types of antidiabetic agents are continually needed with diabetes becoming the epidemic in the world. Indole alkaloids play an important role in natural products owing to their variable structures and versatile biological activities like anticonvulsant, anti-inflammatory, antidiabetic, antimicrobial, and anticancer activities, which are a promising source of novel antidiabetic drugs discovery. The synthesized indole derivatives possess similar properties to natural indole alkaloids. In the last two decades, more and more indole derivatives have been designed and synthesized for searching their bioactivities. This present review describes comprehensive structures of indole compounds with the potential antidiabetic activity including natural indole alkaloids and the synthetic indole derivatives based on the structure classification, summarizes their approaches isolated from natural sources or by synthetic methods, and discusses the antidiabetic effects and the mechanisms of action. Furthermore, this review also provides briefly synthetic procedures of some important indole derivatives.
Collapse
Affiliation(s)
- Yuqian Zhu
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China
| | - Jinran Zhao
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China
| | - Longbiao Luo
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China
| | - Yang Gao
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China
| | - He Bao
- Department of Pharmacy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, China
| | - Pengfei Li
- Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China
| | - Hailong Zhang
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.
| |
Collapse
|
5
|
Alicic RZ, Cox EJ, Neumiller JJ, Tuttle KR. Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence. Nat Rev Nephrol 2021; 17:227-244. [PMID: 33219281 DOI: 10.1038/s41581-020-00367-2] [Citation(s) in RCA: 84] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/16/2020] [Indexed: 01/30/2023]
Abstract
As the prevalence of diabetes continues to climb, the number of individuals living with diabetic complications will reach an unprecedented magnitude. The emergence of new glucose-lowering agents - sodium-glucose cotransporter 2 inhibitors and incretin therapies - has markedly changed the treatment landscape of type 2 diabetes mellitus. In addition to effectively lowering glucose, incretin drugs, which include glucagon-like peptide 1 receptor (GLP1R) agonists and dipeptidyl peptidase 4 (DPP4) inhibitors, can also reduce blood pressure, body weight, the risk of developing or worsening chronic kidney disease and/or atherosclerotic cardiovascular events, and the risk of death. Although kidney disease events have thus far been secondary outcomes in clinical trials, an ongoing phase III trial in patients with diabetic kidney disease will test the effect of a GLP1R agonist on a primary kidney disease outcome. Experimental data have identified the modulation of innate immunity and inflammation as plausible biological mechanisms underpinning the kidney-protective effects of incretin-based agents. These drugs block the mechanisms involved in the pathogenesis of kidney damage, including the activation of resident mononuclear phagocytes, tissue infiltration by non-resident inflammatory cells, and the production of pro-inflammatory cytokines and adhesion molecules. GLP1R agonists and DPP4 inhibitors might also attenuate oxidative stress, fibrosis and cellular apoptosis in the kidney.
Collapse
Affiliation(s)
- Radica Z Alicic
- Providence Medical Research Center, Providence Health Care, Spokane, WA, USA.,Department of Medicine, University of Washington School of Medicine, Spokane and Seattle, WA, USA
| | - Emily J Cox
- Providence Medical Research Center, Providence Health Care, Spokane, WA, USA
| | - Joshua J Neumiller
- Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA
| | - Katherine R Tuttle
- Providence Medical Research Center, Providence Health Care, Spokane, WA, USA. .,Nephrology Division, Kidney Research Institute and Institute of Translational Health Sciences, University of Washington, Spokane and Seattle, WA, USA.
| |
Collapse
|
6
|
He J, Chu Y. Small-molecule GLP-1 secretagogs: challenges and recent advances. Drug Discov Today 2020; 25:S1359-6446(20)30308-1. [PMID: 32835725 DOI: 10.1016/j.drudis.2020.08.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Revised: 07/05/2020] [Accepted: 08/06/2020] [Indexed: 12/14/2022]
Abstract
Glucagon-like peptide-1 (GLP-1) is a potent anti-hyperglycemic hormone that is an alternative treatment choice for patients with type 2 diabetes mellitus (T2DM). The glucose-dependent mechanism of GLP-1 is particularly important because it does not stimulate insulin secretion and cause hypoglycemia when plasma glucose concentrations are in the normal fasting range. Although several peptide drugs of GLP-1 analogs are clinically available, research on the small molecules that stimulate GLP-1 secretion is still struggling. In this review, we summarize recent updates in the discovery of small-molecule GLP-1 secretagogs targeting the G-protein-coupled receptor (GPCR) family. We also discuss the challenges and strategies for the study and describe the latest developments.
Collapse
Affiliation(s)
- Jie He
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China
| | - Yong Chu
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, China.
| |
Collapse
|
7
|
Touchette SJ, Dunkley EM, Lowder LL, Wu J. Nucleophile-intercepted Beckmann fragmentation reactions. Chem Sci 2019; 10:7812-7815. [PMID: 31588331 PMCID: PMC6761917 DOI: 10.1039/c9sc00926d] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Accepted: 06/22/2019] [Indexed: 11/25/2022] Open
Abstract
We describe the first examples of nucleophile-intercepted Beckmann fragmentations of indoline oximes. This reaction uses MsCl as a promoter to give cyano chlorides and is believed to proceed through an aziridinium intermediate via a double stereoinvertive process. Mechanistic insights have led to the further discovery that oxygen, nitrogen, and bromide nucleophiles can be employed for this fragmentation by the use of other promoters. We envision that these products may be useful in the syntheses of members of the akuammiline and koumine families of indoline alkaloids.
Collapse
Affiliation(s)
- Samuel J Touchette
- Department of Chemistry , Dartmouth College , Hanover , New Hampshire 03755 , USA .
| | - Evan M Dunkley
- Department of Chemistry , Dartmouth College , Hanover , New Hampshire 03755 , USA .
| | - Leah L Lowder
- Department of Chemistry , Dartmouth College , Hanover , New Hampshire 03755 , USA .
| | - Jimmy Wu
- Department of Chemistry , Dartmouth College , Hanover , New Hampshire 03755 , USA .
| |
Collapse
|
8
|
Pinho A, Fortuna A, Falcão A, Santos A, Seiça R, Estevens C, Veiga F, Ribeiro A. Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices. J Pharm Anal 2019; 9:143-155. [PMID: 31297291 PMCID: PMC6598173 DOI: 10.1016/j.jpha.2019.02.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Revised: 01/13/2019] [Accepted: 02/10/2019] [Indexed: 12/15/2022] Open
Abstract
The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1 analogs, brought changes in type 2 diabetes treatment options. For better therapeutic efficiency, these active pharmaceutical ingredients require appropriate administration, without the development of adverse effects or toxicity. Therefore, it is required to develop several quantification methods for GLP-1 analogs products, in order to achieve the therapeutic goals, among which ELISA and HPLC arise. These methods are developed, optimized and validated in order to determine GLP-1 analogs, not only in final formulation of the active pharmaceutical ingredient, but also during preclinical and clinical trials assessment. This review highlights the role of ELISA and HPLC methods that have been used during the assessment for GLP-1 analogs, especially for exenatide.
Collapse
Affiliation(s)
- A.R. Pinho
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - A. Fortuna
- Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- CNC – Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal
| | - A. Falcão
- Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- CNC – Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal
| | - A.C. Santos
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - R. Seiça
- Laboratory of Physiology, IBILI, Faculty of Medicine, University of Coimbra, Pólo das Ciênicas da Saúde, Azinhaga de Sante Comba, 300-548 Coimbra, Portugal
| | - C. Estevens
- Pharmaceutical Development, TECNIMEDE, S. A. Quinta da Cerca, Caixaria, 2565-187 Dois Portos, Portugal
| | - F. Veiga
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - A.J. Ribeiro
- Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- I3S, Instituto de Investigação e Inovação em Saúde, Group Genetics of Cognitive Dysfunction, IBMC – Instituto de Biologia Molecular e Celular, Rua do Campo Alegre 823, 4150-180 Porto, Portugal
| |
Collapse
|
9
|
Ma W, Chen X, Cerne R, Syed SK, Ficorilli JV, Cabrera O, Obukhov AG, Efanov AM. Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel. J Biol Chem 2018; 294:2935-2946. [PMID: 30587572 DOI: 10.1074/jbc.ra118.005504] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 12/10/2018] [Indexed: 12/22/2022] Open
Abstract
Estrogen hormones play an important role in controlling glucose homeostasis and pancreatic β-cell function. Despite the significance of estrogen hormones for regulation of glucose metabolism, little is known about the roles of endogenous estrogen metabolites in modulating pancreatic β-cell function. In this study, we evaluated the effects of major natural estrogen metabolites, catechol estrogens, on insulin secretion in pancreatic β-cells. We show that catechol estrogens, hydroxylated at positions C2 and C4 of the steroid A ring, rapidly potentiated glucose-induced insulin secretion via a nongenomic mechanism. 2-Hydroxyestrone, the most abundant endogenous estrogen metabolite, was more efficacious in stimulating insulin secretion than any other tested catechol estrogens. In insulin-secreting cells, catechol estrogens produced rapid activation of calcium influx and elevation in cytosolic free calcium. Catechol estrogens also generated sustained elevations in cytosolic free calcium and evoked inward ion current in HEK293 cells expressing the transient receptor potential A1 (TRPA1) cation channel. Calcium influx and insulin secretion stimulated by estrogen metabolites were dependent on the TRPA1 activity and inhibited with the channel-specific pharmacological antagonists or the siRNA. Our results suggest the role of estrogen metabolism in a direct regulation of TRPA1 activity with potential implications for metabolic diseases.
Collapse
Affiliation(s)
- Wenzhen Ma
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| | - Xingjuan Chen
- the Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana 46202
| | - Rok Cerne
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| | - Samreen K Syed
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| | - James V Ficorilli
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| | - Over Cabrera
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| | - Alexander G Obukhov
- the Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana 46202
| | - Alexander M Efanov
- From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 and
| |
Collapse
|
10
|
She YS, Ma LQ, Liu BB, Zhang WJ, Qiu JY, Chen YY, Li MY, Xue L, Luo X, Wang Q, Xu H, Zang DA, Zhao XX, Cao L, Shen J, Peng YB, Zhao P, Yu MF, Chen W, Nie X, Shen C, Chen S, Chen S, Qin G, Dai J, Chen J, Liu QH. Semen cassiae Extract Inhibits Contraction of Airway Smooth Muscle. Front Pharmacol 2018; 9:1389. [PMID: 30564120 PMCID: PMC6288305 DOI: 10.3389/fphar.2018.01389] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Accepted: 11/12/2018] [Indexed: 12/17/2022] Open
Abstract
β2-adrenoceptor agonists are commonly used as bronchodilators to treat obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD), however, they induce severe side effects. Therefore, developing new bronchodilators is essential. Herbal plants were extracted and the extracts’ effect on airway smooth muscle (ASM) precontraction was assessed. The ethyl alcohol extract of semen cassiae (EESC) was extracted from Semen cassia. The effects of EESC on the ACh- and 80 mM K+-induced sustained precontraction in mouse and human ASM were evaluated. Ca2+ permeant ion channel currents and intracellular Ca2+ concentration were measured. HPLC analysis was employed to determine which compound was responsible for the EESC-induced relaxation. The EESC reversibly inhibited the ACh- and 80 mM K+-induced precontraction. The sustained precontraction depends on Ca2+ influx, and it was mediated by voltage-dependent L-type Ca2+ channels (LVDCCs), store-operated channels (SOCs), TRPC3/STIM/Orai channels. These channels were inhibited by aurantio-obtusin, one component of EESC. When aurantio-obtusin removed, EESC’s action disappeared. In addition, aurantio-obtusin inhibited the precontraction of mouse and human ASM and intracellular Ca2+ increases. These results indicate that Semen cassia-contained aurantio-obtusin inhibits sustained precontraction of ASM via inhibiting Ca2+-permeant ion channels, thereby, which could be used to develop new bronchodilators.
Collapse
Affiliation(s)
- Yu-Shan She
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Li-Qun Ma
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Bei-Bei Liu
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Wen-Jing Zhang
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Jun-Ying Qiu
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Yuan-Yuan Chen
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Meng-Yue Li
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Lu Xue
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Xi Luo
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Qian Wang
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Hao Xu
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Dun-An Zang
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Xiao-Xue Zhao
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Lei Cao
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Jinhua Shen
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Yong-Bo Peng
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Ping Zhao
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Meng-Fei Yu
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Weiwei Chen
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| | - Xiaowei Nie
- Lung Transplant Group, Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Wuxi People's Hospital, Nanjing Medical University, Jiangsu, China
| | - Chenyou Shen
- Lung Transplant Group, Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Wuxi People's Hospital, Nanjing Medical University, Jiangsu, China
| | - Shu Chen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Shanshan Chen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Gangjian Qin
- Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Jiapei Dai
- Wuhan Institute for Neuroscience and Engineering, South-Central University for Nationalities, Wuhan, China
| | - Jingyu Chen
- Lung Transplant Group, Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Wuxi People's Hospital, Nanjing Medical University, Jiangsu, China
| | - Qing-Hua Liu
- Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area, Institute for Medical Biology, College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| |
Collapse
|
11
|
Christiaens M, Hullaert J, Van Hecke K, Laplace D, Winne JM. Stereoselective and Modular Assembly Method for Heterocycle-Fused Daucane Sesquiterpenoids. Chemistry 2018; 24:13783-13787. [DOI: 10.1002/chem.201803248] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Indexed: 01/31/2023]
Affiliation(s)
- Mien Christiaens
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| | - Jan Hullaert
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| | - Kristof Van Hecke
- Department of Chemistry; Ghent University; Krijgslaan 281 S3 Gent 9000 Belgium
| | - Duchan Laplace
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| | - Johan M. Winne
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| |
Collapse
|
12
|
Gelis C, Levitre G, Merad J, Retailleau P, Neuville L, Masson G. Highly Diastereo- and Enantioselective Synthesis of Cyclohepta[b
]indoles by Chiral-Phosphoric-Acid-Catalyzed (4+3) Cycloaddition. Angew Chem Int Ed Engl 2018; 57:12121-12125. [DOI: 10.1002/anie.201807069] [Citation(s) in RCA: 53] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Indexed: 12/15/2022]
Affiliation(s)
- Coralie Gelis
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Guillaume Levitre
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Jérémy Merad
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Pascal Retailleau
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Luc Neuville
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Géraldine Masson
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| |
Collapse
|
13
|
Gelis C, Levitre G, Merad J, Retailleau P, Neuville L, Masson G. Highly Diastereo- and Enantioselective Synthesis of Cyclohepta[b
]indoles by Chiral-Phosphoric-Acid-Catalyzed (4+3) Cycloaddition. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201807069] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Coralie Gelis
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Guillaume Levitre
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Jérémy Merad
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Pascal Retailleau
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Luc Neuville
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| | - Géraldine Masson
- Institut de Chimie des Substances Naturelles CNRS; Univ. Paris-Sud; 1 Avenue de la Terrasse 91198 Gif-sur-Yvette Cedex France
| |
Collapse
|
14
|
Hullaert J, Winne JM. (5,6-Dihydro-1,4-dithiin-2-yl)methanol as a Versatile Allyl-Cation Equivalent in (3+2) Cycloaddition Reactions. Angew Chem Int Ed Engl 2018; 55:13254-13258. [PMID: 27653810 DOI: 10.1002/anie.201606411] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Revised: 08/12/2016] [Indexed: 12/15/2022]
Abstract
The title heterocyclic alcohol readily generates a sulfur-substituted allylic cation upon simple treatment with a protic acid, thus facilitating a synthetically useful stepwise (3+2) cycloaddition reaction pathway with a range of conjugated-olefin-type substrates. The introduction of an allyl fragment in this way provided rapid access to a variety of cyclopentanoid scaffolds. The cyclic nature of the cation precursor alcohol was shown to be instrumental for efficient cycloaddition reactions to take place, thus indicating an attractive strategy for controlling the reactivity of heteroatom-substituted allyl cations. The formal cycloaddition reaction is highly regio- and stereoselective and was also used for a short total synthesis of the natural product cuparene in racemic form through a cycloaddition-hydrodesulfurization sequence.
Collapse
Affiliation(s)
- Jan Hullaert
- Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 S4, Gent, 9000, Belgium
| | - Johan M Winne
- Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 S4, Gent, 9000, Belgium.
| |
Collapse
|
15
|
Seo DY, Kim G, Jo HY, Kim JN. Synthesis of Cyclopentadiindolyl Spirooxindoles via Palladium-catalyzed Intramolecular Oxidative Indole-Indole Coupling Reaction. B KOREAN CHEM SOC 2018. [DOI: 10.1002/bkcs.11432] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Da Young Seo
- Department of Chemistry and Institute of Basic Science; Chonnam National University; Gwangju 500-757 South Korea
| | - Gieun Kim
- Department of Chemistry and Institute of Basic Science; Chonnam National University; Gwangju 500-757 South Korea
| | - Hwi Yul Jo
- Department of Chemistry and Institute of Basic Science; Chonnam National University; Gwangju 500-757 South Korea
| | - Jae Nyoung Kim
- Department of Chemistry and Institute of Basic Science; Chonnam National University; Gwangju 500-757 South Korea
| |
Collapse
|
16
|
Luo X, Xue L, Xu H, Zhao QY, Wang Q, She YS, Zang DA, Shen J, Peng YB, Zhao P, Yu MF, Chen W, Ma LQ, Chen S, Chen S, Fu X, Hu S, Nie X, Shen C, Zou C, Qin G, Dai J, Ji G, Su Y, Hu S, Chen J, Liu QH. Polygonum aviculare L. extract and quercetin attenuate contraction in airway smooth muscle. Sci Rep 2018; 8:3114. [PMID: 29449621 PMCID: PMC5814568 DOI: 10.1038/s41598-018-20409-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2016] [Accepted: 11/22/2017] [Indexed: 01/09/2023] Open
Abstract
Because of the serious side effects of the currently used bronchodilators, new compounds with similar functions must be developed. We screened several herbs and found that Polygonum aviculare L. contains ingredients that inhibit the precontraction of mouse and human airway smooth muscle (ASM). High K+-induced precontraction in ASM was completely inhibited by nifedipine, a selective blocker of L-type voltage-dependent Ca2+ channels (LVDCCs). However, nifedipine only partially reduced the precontraction induced by acetylcholine chloride (ACH). Additionally, the ACH-induced precontraction was partly reduced by pyrazole-3 (Pyr3), a selective blocker of TRPC3 and stromal interaction molecule (STIM)/Orai channels. These channel-mediated currents were inhibited by the compounds present in P. aviculare extracts, suggesting that this inhibition was mediated by LVDCCs, TRPC3 and/or STIM/Orai channels. Moreover, these channel-mediated currents were inhibited by quercetin, which is present in P. aviculare extracts. Furthermore, quercetin inhibited ACH-induced precontraction in ASM. Overall, our data indicate that the ethyl acetate fraction of P. aviculare and quercetin can inhibit Ca2+-permeant LVDCCs, TRPC3 and STIM/Orai channels, which inhibits the precontraction of ASM. These findings suggest that P. aviculare could be used to develop new bronchodilators to treat obstructive lung diseases such as asthma and chronic obstructive pulmonary disease.
Collapse
Affiliation(s)
- Xi Luo
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Lu Xue
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Hao Xu
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Qing-Yang Zhao
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Qian Wang
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Yu-Shan She
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Dun-An Zang
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Jinhua Shen
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Yong-Bo Peng
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Ping Zhao
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Meng-Fei Yu
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Weiwei Chen
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Li-Qun Ma
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China
| | - Shu Chen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430032, Hubei, China
| | - Shanshan Chen
- Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430032, Hubei, China
| | - Xiangning Fu
- Department of Thoracic, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430032, Hubei, China
| | - Sheng Hu
- Department of Medical Oncology, Hubei Cancer Hospital, Wuhan, 430079, Hubei, China
| | - Xiaowei Nie
- Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Lung Transplant Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu, China
| | - Chenyou Shen
- Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Lung Transplant Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu, China
| | - Chunbin Zou
- Acute Lung Injury Center of Excellence, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine., Pittsburgh, PA, 15213, USA
| | - Gangjian Qin
- Department of Biomedical Engineering, School of Medicine & School of Engineering, University of Alabama Birmingham, Birmingham, AL, 35294, USA
| | - Jiapei Dai
- Wuhan Institute for Neuroscience and Engineering, South-Central University for Nationalities, Wuhan, 430074, China
| | - Guangju Ji
- National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China
| | - Yunchao Su
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA
| | - Shen Hu
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA
| | - Jingyu Chen
- Jiangsu Key Laboratory of Organ Transplantation, Department of Cardiothoracic Surgery, Lung Transplant Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu, China.
| | - Qing-Hua Liu
- Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central University for Nationalities, Wuhan, 430074, China.
| |
Collapse
|
17
|
Jo S, Chen J, Xu G, Grayson TB, Thielen LA, Shalev A. miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 2018; 67:256-264. [PMID: 29101219 PMCID: PMC5780066 DOI: 10.2337/db17-0506] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Accepted: 10/30/2017] [Indexed: 12/18/2022]
Abstract
Glucagon-like peptide 1 receptor (GLP1R) agonists are widely used to treat diabetes. However, their function is dependent on adequate GLP1R expression, which is downregulated in diabetes. GLP1R is highly expressed on pancreatic β-cells, and activation by endogenous incretin or GLP1R agonists increases cAMP generation, which stimulates glucose-induced β-cell insulin secretion and helps maintain glucose homeostasis. We now have discovered that the highly β-cell-enriched microRNA, miR-204, directly targets the 3' UTR of GLP1R and thereby downregulates its expression in the β-cell-derived rat INS-1 cell line and primary mouse and human islets. Furthermore, in vivo deletion of miR-204 promoted islet GLP1R expression and enhanced responsiveness to GLP1R agonists, resulting in improved glucose tolerance, cAMP production, and insulin secretion as well as protection against diabetes. Since we recently identified thioredoxin-interacting protein (TXNIP) as an upstream regulator of miR-204, we also assessed whether in vivo deletion of TXNIP could mimic that of miR-204. Indeed, it also enhanced islet GLP1R expression and GLP1R agonist-induced insulin secretion and glucose tolerance. Thus, the present studies show for the first time that GLP1R is under the control of a microRNA, miR-204, and uncover a previously unappreciated link between TXNIP and incretin action.
Collapse
Affiliation(s)
- SeongHo Jo
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| | - Junqin Chen
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| | - Guanlan Xu
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| | - Truman B Grayson
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| | - Lance A Thielen
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| | - Anath Shalev
- Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL
| |
Collapse
|
18
|
Hullaert J, Winne JM. (5,6-Dihydro-1,4-dithiin-2-yl)methanol as a Versatile Allyl-Cation Equivalent in (3+2) Cycloaddition Reactions. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201606411] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Jan Hullaert
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| | - Johan M. Winne
- Department of Organic and Macromolecular Chemistry; Ghent University; Krijgslaan 281 S4 Gent 9000 Belgium
| |
Collapse
|